An interventional study of Taichi and Baduanjin in Visual Impairments, sponsored by Northeast Normal University. Enrolling by invitation at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-04.
Sponsored by Northeast Normal University · Not applicable, Interventional, and Treatment
This study aims to investigate the benefits and underlying mechanisms of traditional exercise interventions on the physical and mental health of individuals with visual impairments. A randomized controlled trial design will be employed, enrolling 90 visually impaired participants who will be randomly assigned to one of three groups: a Tai Chi intervention group, a Baduanjin intervention group, or a control group. The Tai Chi group will undergo a 12-week simplified 21-form Tai Chi training program, while the Baduanjin group will receive standardized Baduanjin training. The control group will participate in regular school physical education classes. Eligible participants are university students with visual impairments, defined as having visual acuity ≤ 0.05 or a visual field radius ≤ 10 degrees.
360 studies on the registry are indexed under Vision Disorders; 84 are open to participants now.
This study's planned enrollment of 90 is above the median of 78 across 244 interventional studies indexed under Vision Disorders.
Browse Vision Disorders studies →Northeast Normal University is the lead sponsor of 13 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: Baduanjin
Behavioral: Taichi
Participants in the Tai Chi group will receive a 12-week simplified 21-form Tai Chi training program. The intervention will consist of supervised sessions conducted three times per week, each lasting approximately 60 minutes. Sessions will include a standardized warm-up, instruction and practice of the 21-form Tai Chi routine, and a brief cool-down period. All training will be delivered by certified Tai Chi instructors experienced in working with individuals with visual impairments. Attendance and adherence will be monitored throughout the intervention period.
Participants in the Baduanjin group will undergo a 12-week standardized Baduanjin training program. The intervention will be delivered three times per week, with each supervised session lasting approximately 60 minutes. Training sessions will include a structured warm-up, guided practice of the standardized Baduanjin routine, and a brief cool-down period. All sessions will be led by qualified instructors with experience working with visually impaired individuals. Participant attendance and adherence will be recorded throughout the intervention period.
Single-Leg Stance Test
Assessment of static balance ability by measuring the duration participants can maintain a single-leg stance before and after the intervention.
Time frame: Month 3
Timed Up-and-Go (TUG) Test
Evaluation of dynamic balance and functional mobility using the timed up-and-go test, recorded at baseline and post-intervention.
Time frame: Month 3
Berg Balance Scale (BBS)
Measurement of overall balance performance using the 14-item Berg Balance Scale, administered before and after the intervention.
Time frame: Month 3
Six-Minute Walk Test (6MWT)
Assessment of cardiorespiratory endurance using the six-minute walk test at baseline and following the intervention.
Time frame: Month 3
Handgrip Strength Test
Evaluation of upper-limb muscular strength using a calibrated handgrip dynamometer, performed before and after the intervention.
Time frame: Month 3
Flexibility Test
Measurement of lower-body flexibility using a standardized sit-and-reach test conducted at baseline and post-intervention.
Time frame: Month 3
Self-Rated Depression Scale (SDS)
Assessment of depressive symptoms using the Self-Rated Depression Scale before and after the intervention.
Time frame: Month 3
Self-Rated Anxiety Scale (SAS)
Evaluation of anxiety symptoms using the Self-Rated Anxiety Scale administered at baseline and post-intervention.
Time frame: Month 3
General Self-Efficacy Scale (GSES)
Measurement of perceived self-efficacy using the General Self-Efficacy Scale at baseline and after the intervention.
Time frame: Month 3
WHO Quality of Life-BREF (WHOQOL-BREF)
Assessment of overall quality of life across physical, psychological, social, and environmental domains using the WHOQOL-BREF questionnaire, conducted before and after the intervention.
Time frame: Month 3
Plan to share: Undecided
No publications or documents are linked to this record.
Started Nov 2025 (actual). Primary completion is estimated for Jan 2026, 2 months after the start.
Of 84 non-industry interventional studies with no phase under Vision Disorders, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 51. This study's planned 2 months is below that.
Counting every sponsor, half of 94 studies reached it within 24 months; a quarter within 6 and three quarters within 51.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Northeast Normal University